Marked Chart Marked Chart Closed · opens Mon 9:30 AM ET

The Marked Chart Wire · Business

Earnings

Rapport Therapeutics surges on bipolar trial success; Vicor and MSCI beat earnings

Rapport Therapeutics shares jump 28 percent after a bipolar drug trial meets its goals. Vicor and MSCI report strong third-quarter results, while FreightCar America drops 19 percent after cutting its outlook.

VICR-2.2%MSCI-0.7%HAL+5.2%EFX-2.5%

Illustration for the Business desk

More Business news

Fast headlines, summarized. Not verified and not advice. Check the full story before you act.